Vitarka Therapeutics Pre-Seed
vitarka.co.uk
Biotechnology
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
51-200
employees, estimated range
Backers
2
SOSV, Future Planet Capital
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
SOSV 
Future Planet Capital Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Aardaia invents new crops from first principles, starting with the aardaker: a nitrogen-fixing, tuber-forming protein crop.
Build next-generation cell engineering and drug discovery workflows with Portal mechanoporation for broad intracellular delivery across…
BioSapien's MediChip™ delivers sustained cancer therapy directly at the tumor site while minimizing systemic exposure through localized…
We offer microneedle applicators for Drug Delivery and Biosensing.
Etherna pioneers in mRNA-LNP platforms, offering custom drug delivery platforms for tailored and innovative LNP drug delivery solutions.
Antiverse combines generative AI and advanced antibody discovery to design functional, developable biologics for challenging drug targets.
News
Vitarka Therapeutics appoints Dr John Beadle as Chairman of the Board
London, 27 November 2024: Vitarka Therapeutics Ltd, the EndoPore cancer therapeutics company, today announced the appointment of Dr John Beadle as the new Chairman of the Board. Vitarka is an innovative biotechnology company developing EndoPore, a highly
Read more
Report
2024 Winners
Many thanks to everyone who took the time to enter this year and congratulations to the 2024 OBN Awards winners & finalists:View our 2024 winners press release: HEREBioSeed 'One to Watch' AwardKindly sponsored by Partners&Partners&Winner: Vitarka Therapeu
Read more
Report
Dr Jim Faulkner joins Vitarka's Board as Non-executive Director
Jim Faulkner, NED of Vitarka Therapeutics Vitarka Therapeutics Ltd, a preclinical stage Biotech company developing targeted non-viral delivery technology has appointed Jim Faulkner as a new Non-Executive Director to its Board of Directors. Dr Faulkner has
Read more
Report
winners and runner-ups very first Inspirational Women Awards at Discovery Park!
Congratulations to the winners and runner-ups of our very first Inspirational Women Awards at Discovery Park! With over 70 nominations across our four different award categories, we're grateful to have so many inspirational women in pivotal roles within t
Read more
Report
Announcing the 2024 Human Health 100
Welcome to the third annual SOSV Human Health 100. The list features SOSV's 100 most exciting companies in the health category, which for SOSV ranges very widely, from assistive robotics and remote care to therapeutics and diagnostics. In the past two yea
Read more
Report
£13 million to help transform medicines manufacturing
Seventeen new projects will receive funding for cutting edge medicine manufacturing, delivered by the Innovate UK Transforming Medicine Manufacturing programme.Today, Innovate UK, the UK's innovation agency, is pleased to announce the winners of a series
Read more
Report
UK biotech start-up secures £1.27M to revolutionise intracellular drug delivery through tumour targeted technology
A female-led preclinical biotech start-up Vitarka Therapeutics, focused on revolutionising the market for non-viral drug delivery technology, has raised £1.27Min equity from venture capital firm SOSV, the UK Innovation & Science Seed Fund (UK12S) and gran
Read more
Report
Notes on Disparity from a Female CEO
Do investors scrutinize CEOs more closely when they are women? It may not always be intentional, but research shows that subconscious bias does exist.I have a vision for my company. I want us to be the market leader for non-viral drug delivery technology.
Read more
Report
New York Batch 5
IBNY05's In-Person Preview will take place on Feb 1, 2023, and our Online Demo Day will be on Feb 7, 2023. Please sign up for our newsletter to get exclusive announcements from our companies and for Demo Day. Updated Jan 19, 2023. Vitarka TherapeuticsCuri
Read more
Report
61. Vineeta Tripathi, Vitarka Therapeutics - From scientist to CEO
Dr Vineeta Tripathi is the founder of Vitarka Theraputics, a biotech start-up developing technology to unleash the power of RNA therapeutics, a new class of medications which will help combat untreated late-stage cancers. Vineeta founded the company in 20
Read more
Report